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.£13 PURPOSE OF THESIS 
The purpose of this project is to synthesize the isoamyl ester 
7-N-acetyl-ll'-hydroxy-3'demethyllavendamycin which may 
potentially be an antitumor drug. Similar compounds have been 
previously made in our laboratory, but this new compound has two 
distinctly different groups attached to the N-acetyllavendamycin 
backbone. These groups will hopefully increase the solubility of 
the compound in water, thus making it a more practical drug for use 
in humans, as well as increasing its selectivity in destroying the 
cancer cells relative to the normal cells. The new compound will 
be sent to Eli Lilly for testing first in vitro, and then in 
animals to determine its selectivity and toxicity. Lavendamycin-
based drugs offer some hope in treating certain kinds of human 
cancers for which there are no drugs at the present time. 
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HISTORICAL 
LAVENDAXYCIN 
I. BACKGROUND 
The ant.i tumor, antibiotic Lavendamycin (1a) bears a close 
resemblance to the potent antitumor, antibiotic streptonigrin (2). 
Lavendamycin was first isolated in 1981 from streptomyces 
lavendulae strain c22030. Lavendamycin was obtained as a dark, red 
solid, rnp > 300·, with only limited solubility in organic 
solvents. 1 As an antibiotic, Lavendamycin is generally less potent 
than streponigrin. The exceptions lie in the lavendamycin 
inhibition of Trichophton and Microsporum. 
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1a NH2 H H CH3 
1b NHz CH3 H CH3 
4 NHAc CH3 H CH3 
5 NHAc (CH2) 2CH (CH3 ) 2 OH H 
Table 12 
minimum inhibitory concentration (~g/ml) 
Organism strain Lavendamycin streptonigrin 
Trichophyton rub rum WW 0.5 8 
Trichophyton mentagrophytes A-9870 0.5 4 
Microsporum canis A-9872 0.5 16 
Microsporum canis A-22494 0.25 4 
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The potential clinical usage of both Lavendamycin and 
streptonigrin as antitumor drugs has been unsuccessful due to their 
toxicity.2 
Lavendamycin has a B-carboline backbone (3) . B-carbolines and 
their derivatives possess a number of behavioral and neurochemical 
activities. 3 
II. PHARMACOLOGICAL STUDIES 
In an in vitro drug screen, N-acetyllavendamycin methyl 
ester (4) had shown high selective cytotoxicity for rask transformed 
epithelial cells, compared to the normal cells. The rask oncogene 
is associated with 90% of pancreatic solid tumors in humans, 60% of 
colon tumors, and 30% of· breast cancer tumors. compound ( 4 ) 
selective cytotoxicity is unprecedented and marks an exciting 
advancement, as there is currently no drug that cures these 
tumors. 4 
3 
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III. SYNTHESIS 
In 1984, the first total synthesis of Lavendamycin methyl 
ester(lb) was reported by a team at the University of Rochester. 5 
The precursor used was B-methyl tryptophan. Recently Behforouz and 
co-workers have found an efficient route for the synthesis of 
lavendamycin methyl ester(lb).6 
A. Synthesis of Lavendamycin methyl esterC1b) and its N-
Acetyl Derivative(4) 
The new and efficient route referred to above was carried out 
by the Pictet-Spengler condensation of aldehyde (8) with B-
methyl tryptophan methyl ester(10) in refluxing xylene to give N-
Acetyllavendamycin methyl ester (4) in 79% yield. Hydrolysis of (4) 
in a mixture of trifluoroacetic acid and water produced 
lavendamycin methyl ester(lb) in 91% yield (Scheme 1).3 
o 
CHO + xylene 
o o 
AcHN 
SCHEME I 
4 
--
o 
Ib 
IV. PROPOSAL FOR THE SYNTHESIS OF THE NEW COMPOUND 7-N-ACETYL-ll, -
HYDROXY-3'-DEMETHYLLAVENDAMYCIN ISOAMYL ESTER(S) 
Lavendamycin methyl ester is a very insoluble compound and 
consequently, it is difficult to be introduced into animals for 
screening tests. More soluble analogs of this compound are 
desired. The addition of a hydroxyl group to the lavendamycin 
backbone will hopefully increase the solubility of the compound in 
water, making it more suitable for introduction into animals. The 
location of the hydroxyl group also makes the compound similar to 
the naturally occurring Serotonin(6) found in the human brain. The 
isoamyl group at the C-2 I position will hopefully increase the 
selective cytotoxicity. The antitumor activity of compound (5) and 
a number of other lavendamycin analogs prepared by other members of 
our research group will be studied, and the results will be 
compared. Based on this study, the minimum potent structure will 
be determined, and possibly the mechanism of the action of 
lavendamycin against cancer cells will be clarified. 
HO 
5 
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RESOLTS AND DISCOSSION 
SNTHESIS OF THE ISOAMYL ESTER OF 7-N-ACETYL-ll'-HYDROXY-3'-
DEMETHYLLAVENDAMYCIN 
The maj c)r obj ecti ve of this research was the synthesis of the 
isoamyl esterof 7-N-acetyl-11 '-hydroxy-3 '-demethyllavend amycin(S). 
This compound was produced through the Pictet-Spengler condensation 
of S-Hydroxytryptophan isoamyl ester(7) with 7-Acetamido-2-
formylquinoline-S,8-dione(8) in refluxing dry acetonitrile for 19 
hours. This procedure gave a 6.9% yield of a red solid material 
according to the following scheme (scheme II). 
o 
+ AcHN 
o 
2 
SCHEME II 
AcHN 
CHO 
o 
acetonitrile. 
OH 
Thin Layer Chromatography (silica gel, CH2Cl2 - MeOH, 100:1) 
showed the compound to be pure (Rf=0.4). The structure of 7-N-
acetyl-11'-hydroxy-3'-demethyllavendamycin isoamyl ester was 
,--- confirmed by nmr. The nmr showed traces of unreacted ester, however. 
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SYNTHESIS OF 5-HYDROXYTRYPTOPHAN ISOAMYL BSTER 
5-Hydroxytryptophan isoamyl ester (7) was prepared according to 
a similar method described for the synthesis of B-methyltryptophan 
methyl ester.7 The following scheme was used (scheme III). 
1) HCl isoamyl alcohol 
@ 145-150·C 
SCHEME III 
HO 
z 
Condensation of ~ with an excess of isoamyl alcohol in the 
presence of dry hydrogen chloride at 145-150·C for 24 hours gave 
ester 2 in 80% yield as a dark brown semisolid. Thin layer 
chromatography (silica gel, EtOAc/MeOH 9:1) showed the compound to 
be pure (Rf=0.51). The structure was confirmed by nmr, ir, and 
mass spectroscopy. 
7 
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PREPARATION OF 7-ACETAMIDO-2-FORMYLQUINOLINE-5,8-DIOHB(8) 
7-Acetamino-2-formylquDinoline-5,8-dione(8) was prepared 
according to the following scheme (scheme IV). The procedure was 
similar to that described by A.G. Richardson. 8 
HN03/HzS04 Hz. HCI .. • CH 3 N02 CH3 Pd/C NH2 CH3 
OH OH OH 
11 12 12 a 
NHAe 0 
AC20 KZCrZ07 
• • 
NaZS03 HOAc 
NaOAc ACHN CH 3 ACHN CH 3 
OAe 0 14 
13 
0 
SeOz 
• 1,4 dioxane 
ACHN CHO 
0 
J. 
(SCHEME IV) 
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Compc;mnd 11 was treated with 70% HN03-HzS04 at 0-5·C for 90 
minutes to give a 58% yield of compound 12 as a bright yellow 
solid. 
Reduction of 12 with molecular hydrogen in the presence of 5% 
Palladium on charcoal at 25 ° C for four hours gave a dark red 
mixture. The resulting mixture was filtered off and the filtrate 
was treated with excess acetic anhydride in the presence of sodium 
sulfite and sodium acetate to give an 80% yield of compound 11 as 
a white solid (m.p. 255°C). 
Oxidation of compound 13 in acetic acid by potassium 
dichromate for 20 hours at 25°C gave a 56% yield of compound 14 as 
an orange/yellow solid. 
Oxidation of compound 14 in 1,4-dioxane by selenium oxide for 
24 hours at reflux gave a 73% yield of compound .§. as a yellow 
solid. 
9 
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EXPERIIlENTAL: 
I. GENERAL INFORMATION 
RBAGEN'l'S: 8-Hydroxyquinalidine, palladium on charcoal (5%), 5-
Hydroxy tryptophan 
SOLVEN'l'S: Acetonitrile, 1,4-Dioxane, and Isoamyl alcohol were 
dried and distilled before use. Chloroform, ethyl acetate, ethyl 
ether, dichloromethane, 95% ethanol, and methanol were used without 
distillation. 
MELTING POINTS: Melting points were performed with a Thomas 
Hoover capillary melting point apparatus, and are not corrected. 
NUCLEAR MAGNETIC RESONANCE SPECTRA ('H NHR): NMR spectra were 
recorded on a Varian Gemini 200 in deuterated chloroform (CDCl3 ) 
with TMS as the internal standard. The chemical shifts are 
reported in 6 values. 
THIN LAYER CHROMATOGRAPHY: TLC I S were performed on Kodak 
silica gel sheets containing a fluorescent indicator. 
INFRARED SPECTROSCOPY: IRis were performed on a Nicolet 5ZDX 
FT-IR spectrometer. 
MASS SPECTROSCOPY: Mass spectra were recorded on an Extrel 
ELQ 400 mass spectrometer. 
PLATE CHROMATOGRAPHY: Plate chromatographies were performed 
on Analtech alumina gel thin layer chromatography plates. 
10 
II. PROCEDURE 
A. PREPARATION OF 5,7- DINITRO-8-HYDROXY-2-METHYLQUINOLINE(12) 
In a 500 ml erlenmeyer flask (Note 1), equipped with a 
magnetic stirring device, was placed 100 ml of a 70%(v/v) solution 
of conc. nitric acid-sulfuric acid. The solution was stirred and 
cooled in an ice bath for five minutes. To this solution, 8-
Hydroxyquinaldine (10 g, 62.9 mmol) was added in small portions 
over a five minute period. The addition of the 8-Hydroxyquinaldine 
caused a brownish gas to evolve (Note 2). The mixture was allowed 
to stir in the ice bath for 90 minutes. The mixture appeared black 
with a hint of red. The mixture was then poured into a 1000 ml 
beaker which contained 600 ml of distilled water, and stirred with 
a glass rod. A bright yellow precipitate formed upon the addition 
of the mixture to the water. The precipitate was then either 
vacuum filtered and collected, or it was allowed to stand overnight 
and the supernate was carefully vacuum pipetted out with a pipet 
attached to the aspirator, and followed by a short vacuum 
filtration. The solid material was added to 150 ml of 95% ethanol. 
The precipitate tended to cling to the filter paper, so the filter 
paper was rinsed with 50 ml of 95% ethanol and added to the 
ethanolic mixture in a 500 ml erlenmeyer flask (Note 3). The 
mixture was magnetically stirred for 15 minutes (Note 4). This 
solution was again filtered, and the solid on the funnel was washed 
with ethyl ether (150 ml), with the aspirator off (Note 5). The 
,- solid 5, 7-Dinitro-8-hydroxy-2-methylquinoline was left on the paper 
11 
--
to dry overnight in the hood. The compound was a very bright 
yellow. A greenish tint shows impurity. 
Note 1: The use of a 500 ml flask, instead of a 250 ml flask, will 
greatly lessen the chances of an intense evolution of gas, and an 
overflowing of the mixture during the next procedure. 
Note 2: Be careful! If too much compound is added at once, the 
mixture may overflow. Perform this procedure under g hood only. 
Note 3: The cleaner the filter paper, after rinsing, the higher 
the yield. Get the 'filter paper as clean as possible, sometimes 
"dipping" the paper in ethanol helped to get the compound off of 
the paper. This compound is very "messy," latex gloves and a lab 
coat are highly recommended. 
Note 4: Additional ethanol may have to be added while stirring to 
wash the compound efficiently. The amount of ethanol used here is 
not crucial, since the solution will be filtered later. 
Note 5: The addition of the ether to the solid on the funnel 
caused the paper to be raised up, and the ether seeped under the 
paper, taking some of the product with it. To avoid this, make 
sure the filter paper is secure and tight on the funnel, with no 
bubbles, before beginning the filtration. If unsure of the status 
of the filter paper, add the ether slowly, and do not allow it to 
build up and flow around the edges. 
Yield: 57.5% (9.0 qrams of product) 
Yields of 77% were reported by A.G.Richardson8 
12 
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B. PREPARATION OF 5,7-DIACETAMIDO-2-METHYL-8-ACETOXYQUINOLlBE(13) 
Into a 500 ml hydrogenation bottle, 5,7-Dinitro-8-hydroxy-2-
methylquinoline (6.03 g, 24.2 mmol) , water (100 ml), and conc. HCI 
(13 ml) were added. To this suspension, 5% Palladium on Charcoal 
(2.00 g) was added as a catalyst. This mixture was hydrogenated at 
40 psi overnight (Note 1). The solution was then carefully vacuum 
filtered to remove the PdlC (Note 2) and the filtrate was 
transferred to a 500 ml beaker. To the filtrate, sodium sulfite 
(2.85 g), sodium acetate (3.58 g), and acetic anhydride (2.5 ml) 
were added, using a magnetic stirrer. Generally, no precipitate 
formed. After 30 minutes, the same amount of the above three 
compounds were added again. The slow addition of acetic anhydride 
(7.5 ml) caused a orange/white precipitate to form (Note 3). The 
solution was then vacuum filtered and the precipitate was washed 
three times with water (100 ml). This process washed the orange 
color out of the precipitate, and left a white solid on the filter 
paper. The filtrate was evaporated down to one-quarter of its 
volume. Any precipitate that formed was filtered and washed, as 
above. The filtrate was treated with sodium acetate and acetic 
anhydride aga in until no more precipitate was formed (Note 4). All 
washed precipitates were combined and allowed to dry overnight 
under the hood, or on a vacuum pump. 
13 
-Note 1: The hydrogenation should take place until no more of the 
hydrogen gas is "used" by the reaction. Therefore, do not stop the 
hydrogenation until the rate of pressure decrease falls below 0.5 
psi/hour. This takes approximately four hours. 
Note 2: Do Not rinse the Pd/C that is on the filter paper with 
water! This will dilute the solution, which is concentration 
sensitive. The filtrate should take up, at most, 130 mI. 
Note 3: If after this point, no precipitate has formed, then 
perform the following procedure: 
Using a rotary evaporator and heat, remove the solvent until 
a small amount of solution is obtained. Add the three compounds 
(sodium sulfite, sodium acetate, and acetic anhydride) in small 
quantities (approximately one-quarter of that called for in the 
procedure), and then wait 15 minutes. Next add 5 ml acetic 
anhydride and stir vigorously (use a magnetic stirrer, cover the 
beaker with parafilm, and set the stirrer on maximum). Add small 
amounts of sodium sulfite and sodium acetate while vigorously 
stirring for 10 minutes. stop the stirring and allow the mixture 
to stand, the precipitate should then form. Problems like this can 
be avoided by following the prescribed procedure exactly as 
written. 
Note 4: The addition of the acetic anhydride is what generally 
causes more precipitate to form. 
Yield: 80% (6.05 grams of product [m.p. 255- C]) 
Yields of 88% were reported by A.G.Richardson8 
14 
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C. PREPARATION OF 7-ACETAMIDO-2-KBTHYLQOINOLINE-5,8-DIONE(14) 
Into a 1000 ml erlenmeyer flask, 240 ml of glacial acetic 
acid, and 5,7-0iacetamido-2-methyl-8-acetoxyquinoline (6.3 g, 2.0 
romol) were added. To the resulting suspension, a solution of 
potassium dichromate (17.64 g) in 200 ml of water was added. This 
black soluticm was magnetically stirred at room temperature for 20-
24 hours. The solution was then poured into 900 ml of water and 
extracted with dichloromethane (5 x 200 ml). The organic extracts 
were washed with a solution of 5% sodium carbonate in a saturated 
salt solution (3 x 300 ml). The organic layer was dried overnight 
with anhydrous magnesium sulfate (Note 1). The magnesium sulfate 
was filtered off, and the solvent was evaporated to leave a 
orange/yellow solid. The solid 7-Acetamino-2-methylquinoline-5,8-
dione was dried overnight on the vacuum pump. 
Note 1: The organic layer is more efficiently dried if the flask 
is tightly stoppered, sealed with parafilm, and placed in a cold 
room. 
Yield: 55.65% (2.56 9 of product) 
Yields of 53% were reported by A.G. Richardson8 
15 
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D. PREPARATION OF 7-ACETAMlDO-2-FORMYLQUINOLlNE-S,8-DIONE(8) 
In a dry 100 ml round bottomed flask, equipped with a magnetic 
bar, 2.30 g (10 mmol) of 7-acetamido-2-methylquinoline-5,8-dione 
and 1.388 g (12.5 mmol) of selenium (IV) oxide (note 1) was added 
to 35.0 ml of dried 1,4-dioxane (note 2) and 1.25 ml of water. The 
reaction mixture was heated slowly to reflux over a two hour 
period. The mixture was then refluxed for 24 hours. This reaction 
was carried out under an argon balloon. The completion of the 
reaction was tested by TLC (note 13). To the mixture 35 ml of 
dioxane was added and was allowed to reflux for fifteen more 
minutes. The solution was then hot filtered to remove the black 
selenium metal. The flask was rinsed with approximately 10 ml of 
dichloromethane and poured over the solid on the filter paper. The 
fil trate was then rotary evaporated to dryness. The sol id was 
extracted with 2500 ml of dichloromethane. The filtrate was then 
rotary evaporated to obtain the yellow-tan aldehyde (7-acetamino-2-
formylquinoline-5,8-dione). The product was dried on the vacuum 
pump overnight and a TLC was performed (note 3). When dried, the 
product was yellow in color. 
16 
-Note 1: The purity and quality of the selenium (IV) oxide will 
severely effect the yield. Be sure the selenium (IV) oxide is 
pure~ If it is, it will appear as orange crystals. 
Note 2: Dioxane was refluxed over argon, adding KOH until no more 
black resin appeared. This took approximately 4-6 hours. The 
resin was filtered out and the dioxane was refluxed with sodium 
spheres until they appeared shiny. The dioxane was then distilled. 
Dioxane was kept in an argon atmosphere in a bottle equipped with 
a septum, and removed with a sterile syringe, using an argon 
balloon to regulate the pressure. 
Note 3: Use a solvent system of 100% EtOAc. An Rf value of approx. 
0.51-0.56 indicates completion. There should be one spot. 
Yield: 72~95% (356 mg of product) 
Yields of 80% were reported by A.G. Richardson8 
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E. SYNTHESIS OF 5-BYDROXYTRYPTOPHAN ISOAMYL ESTER (7) 
Into a dry 250 ml round bottomed flask was added 60 ml of 
dried and distilled isoamyl alcohol (note 1). Dry HCl gas was 
bubbled through the isoamyl alcohol for 15 minutes. The HCl tank 
was opened so that it bubbled into the isoamyl alcohol through a 
pipett in a side neck of a three necked round bottomed flask. The 
isoamyl alcohol was kept under an argon stream flowing throug a ITI 
tube at the top of the condenser leading to a concentrated solution 
of sodium hydroxide. To the saturated HCl solution was added 5-
Hydroxy tryptophan (~ 1 gram, 4.54 romol). This created a 
suspension. The reaction mixture was heated in an oil bath to 145 
- 150 0 C. The colorless solution was refluxed for 24 hours (note 
2). The solution was then allowed to cool at room temperature. 
The mixture was evaporated to "dryness" under vacuum to give the 
hydrochloride salt. The oil material was dissolved in 40 ml EtOAc 
and then was treated with 10 - 15 ml of conc. NH40H. The pH of the 
solution was recorded to be ~ 9. This mixture was magnetically 
stirred for 10 minutes. The organic layer was separated and the 
aqueous layer was extracted with EtOAc (2 x 10 ml). The combined 
organic extracts were washed with 25 ml of a saturated NaCl 
solution. The organic layer was separated and dried over anhydrous 
MgS04 for 2 hours or overnight in the cold room. The mixture was 
filtered, and the solution was evaporated to dryness under vacuum. 
Small portions of ethyl ether were added several times to the oil 
,'-" and then evaporated to help the removal of the EtOAc. The TLC with 
18 
-a solvent system of 9:1 EtOAc/MeOH showed one spot (Rf=0.51), but 
the nmr showed traces of EtOAc. To remove the EtOAc, the oil was 
dried overnight on the vacuum pump at 70 0 C. A subsequent nmr 
showed the product to be pure. The 5-Hydroxytryptophan isoamyl 
ester was a dark brown, highly viscous oil, and was stored in the 
cold room. 9 
Yield: approx. 80\ (approx. 1 gram of product) 
'H NMR (CDCI3 , ppm) 8.03 (lH, s, NH), 7.265 (lH, s, C-8 H), 
7.20 (lH, d, J=4.4 Hz, C-6 H), 7.013 (lH, s, C-4 H), 6.75 (lH, d, 
J=0.91 Hz, C-7 H), 4.135 (2H, t, J=7 Hz, COzCHz-), 3.8 (lH, t, J=6 
Hz, C-2 H), 2.95-3.25 (2H, m, HaHb style, C-3 H), 1.54-1.73 (lH, m, 
-CH -) Z ' 1.47-1.53 (lH, rn, -CH'-), 0.896 (6H, d, J=3.1 Hz, C-(CH3)z); 
lR (Neat) vmax 3420 (O-H); 3359,3299 (N-Hz); 3206 (N-H); 3054 (aromatic 
C -H) ; 2959,2929,2872(aliphatic C-H) ; 1729(C=O) ; 
1667,1626,1582 (aromatic C=C); 1468 (-CHz- bending); 1386,1366 (C-
(CH3 ) z bendin~J); 1208 (Ar-O-); 1052 (-CHz-O-); ElMS, role (relative 
intensity) 290 (W, 6.3), 274 (1.5), 216 (7.4), 173 (1.6), 162 
(1.3),158 (1.1), 146 (100), 117 (1.9). 
Note 1: The isoamyl alcohol (3-methyl-1-butanol) was dried over 
anhydrous CuS04 and distilled. The alcohol turned brown upon the 
addition of the CuS04 • The boiling range of the isoamyl alcohol is 
130.5 - 131.5"C. 
Note 2: When the oil bath reached 145°C, the 5-Hydroxytryptophan 
dissolved in the alcohol. 
19 
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F. SYNTHESIS OF THE ISOAMYL ESTER OF 7-N-ACETYL-ll l -BYDROXY-3 1 -
DEMETHYLLAVENDAMYCIN(5) 
Into a dry 150 ml round bottomed flask was added 75 ml of 
dried and distilled acetonitrile (Note 1). To this was added 5-
Hydroxy tryptophan isoamyl ester (1., 56 mg, 0.2 romol), and 7-
Acetamido-2-formylquinoline-5,8-dione (~, 48.8 mg, 0.2 mmol). The 
reaction mixture was heated in an oil bath to 82°C. The lemon 
yellow solution was refluxed for 19 hours. The mixture was then 
evaporated to dryness under vacuum to give a brown solid. The 
solid was then dissloved in a minimal amount of Chloroform and the 
compound was separated by plate chromatography (Rf=0.23) to give 
the red solid lavendamycin derivative. Thin layer chromatography 
(silica gel, CH2Cl2 - MeOH, 100:1) showed the compound to be pure 
(Rf=0.4) . The nmr showed traces of unreacted ester, the 
lavendamycin derivative peaks are listed below (Note 2). 
yield: 6.9% 
'H NMR (CDCl3 , ppm) 11.6(lH, s, NH), 9.16(lH, d, J=4.14 Hz, 
C-4 H), 8.89(lH, s, C-6 H), 8.47 (lH, d, J=13.2 Hz, C-3 H), 8.4(lH, 
s, AcNH), 7.97(lH, s, C-3 1 H), 7.65(lH, d, J=0.91 Hz, C-10
' 
H), 
7.6(lH, s, C-12 1 H), 7.3(lH, d, J=7.4 HZ, C-9 1 H), 4.5(2H, t, J=6 
Hz, C02CH2), 2.0-2.15 (2H, m, C-CH2-), 1.82(lH, q, J=6 Hz, -CH'-), 
1.1(6H, d, J=6 Hz, C-(CH3 )z. 
Note 1: Acetonitrile was dried by distilling over calcium hydride. 
Note 2: The reaction was done twelve times and no pure compound 
was made. The starting materials MUST be pure, and the water 
should be removed effectively from the reaction flask. 
20 
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The following pages contain nmr I ir, and mass spectra for 
compound I, and an nmr spectrum of compound ~. 
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